RTTR - Ritter Pharmaceuticals reports Q1 results May, 01 2020 05:41 PM Ritter Pharmaceuticals Ritter Pharmaceuticals (NASDAQ:RTTR): Q1 GAAP EPS of -$0.05.Cash and cash equivalents of $5.95MPress ReleaseMore news on: Ritter Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,